Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
4.560
-0.200 (-4.20%)
At close: Feb 27, 2026, 4:00 PM EST
4.670
+0.110 (2.41%)
After-hours: Feb 27, 2026, 5:56 PM EST
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $63.71 million as of February 27, 2026. Its market cap has increased by 81.61% in one year.
Market Cap
63.71M
Enterprise Value
31.69M
1-Year Change
81.61%
Ranking
Category
Stock Price
$4.56
Market Cap Chart
Since March 26, 2024, Q32 Bio's market cap has decreased from $199.19M to $63.71M, a decrease of -68.02%. That is a compound annual growth rate of -44.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 66.50M | 62.79% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coeptis Therapeutics Holdings | 68.36M |
| ETHZilla | 67.11M |
| Grace Therapeutics | 66.38M |
| Cingulate | 65.32M |
| NeurAxis | 63.92M |
| Entera Bio | 63.74M |
| InflaRx | 62.33M |
| Alterity Therapeutics | 61.98M |